Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples